No single ticker was named. Healthcare ETFs are one way for retail investors to get exposure. Not a recommendation.
ASCO to drive pharma M&A, especially in oncology
The guest argued the ASCO oncology conference will likely yield more M&A activity, driven by pharma's need to fill pipelines ahead of patent cliffs and pressures from the Inflation Reduction Act.
Sign in to read the full idea
The argument, what validates it, the risks discussed and hearing it from the source are for signed-in members. Free accounts read 3 ideas in full a day. No card required.